Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?
- 1 July 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 2 (4), 297-304
- https://doi.org/10.1161/circoutcomes.108.830232
Abstract
Background— Randomized trials and observational studies support using an international normalized ratio (INR) target of 2.0 to 3.0 for preventing ischemic stroke in atrial fibrillation. We assessed...Keywords
This publication has 49 references indexed in Scilit:
- Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial FibrillationCirculation: Cardiovascular Quality and Outcomes, 2008
- Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysisCMAJ : Canadian Medical Association Journal, 2008
- Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial FibrillationJournal of the American College of Cardiology, 2008
- Death and Disability from Warfarin-Associated Intracranial and Extracranial HemorrhagesAmerican Journal Of Medicine, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCell Metabolism, 2006
- Atrial Fibrillation and Stroke in the General Medicare PopulationStroke, 2006
- Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation StudyJournal of the American Geriatrics Society, 2006
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006
- Risk of bleeding with long-term antithrombotic therapy in atrial fibrillationEuropean Heart Journal Supplements, 2005
- Bleeding complications in oral anticoagulant therapy. An analysis of risk factorsArchives of Internal Medicine, 1993